Eargo (https://eargo.com/), a direct-to-consumer hearing technology company, has announced the closing of the first tranche of an aggregate $45 million Series C investment round, which the company said will be used to accelerate their product innovation. The new investment was led by Nan Fung Life Sciences. New Enterprise Associates, Charles and Helen Schwab, and Maveron have also provided investments. Eargo is designed for consumers with on-the-go lifestyles and the desire for simplicity. Christian Gormsen, the CEO of Eargo, said, "We believe people shouldn't feel that they need a hearing aid. They should feel that they want one. Eargo was created with this in mind and we're just getting started."
Published: 10/27/2017 2:07:00 PM
http://ift.tt/2yaJcAr
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου